An update in pulmonary hypertension in systemic lupus erythematosus - Do we need to know about it?

Lupus

Volumn 18, Issue 1, 2009, Pages 92-

  Minai, O A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; FEMALE; HUMAN; MIDDLE AGED; NOTE; PROGNOSIS; PULMONARY HYPERTENSION; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULAR RESISTANCE;

ADULT; ANTIHYPERTENSIVE AGENTS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PROGNOSIS; VASCULAR RESISTANCE;

EID: 62749111411     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203308098361     Document Type: Letter

References (6)

1. Pope, J. An update in pulmonary hypertension in systemic lupus erythematosus -do we need to know about it. Lupus 2008; 17: 274-277.
2. Badesch, DB, Abman, SH, Ahearn, GS, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: 35S-62S.
3. Sodhi, M, Krasuski, R, Dweik, RA, Minai, OA. Vasoreactivity in pulmonary hypertension. Am J Respir Crit Care Med 2008; 177: A920.
4. Chung, S-M, Lee, C-K, Lee, EY, Yoo, B, Lee, S-D, Moon, H-B. Clinical aspects of pulmonary hypertension in patients with systemic lupus erythematosus and in patients with idiopathic pulmonary arterial hypertension. Clin Rheumatol 2006; 25: 866-872.
5. Barst, RJ, McGoon, M, McLaughlin, VV, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2003; 41: 2119-2125.
6. Heresi, GA, Minai, OA. Lupus-associated pulmonary hypertension: long-term response to vasoactive therapy. Respir Med 2007; 101: 2099-2107.